GSK sells two vaccines to Pfizer to ease competition concerns
June 22, 2015 at 07:45 AM EDT
LONDON, June 22 (Reuters) - GlaxoSmithKline has agreed to sell two meningitis vaccines to Pfizer to satisfy antitrust concerns after its recent acquisition of vaccines business of Novartis.
